Biotek-snakken — September 2020
-
Pfizer, BioNTech propose expanding COVID-19 vaccine trial to 44,000 volunteershttps://www.marketscreener.com/news/latest/Pfizer-BioNTech-propose-expanding-COVID-19-vaccine-trial-to-44-000-volunteers--31285751/
-
Immunometic har 366 medarbejdere og et godkendt stof. Ja 100% premium og vild pris . https://finance.yahoo.com/news/gilead-nears-deal-buy-immunomedics-194905592.html
-
God morgen.
-
Ny stor ADC deal MRK-SGEN. Spændende at se om ADC-aktierne generelt skal have en tur op idag. https://finance.yahoo.com/news/seattle-genetics-merck-announce-two-104500702.html
-
Morgan Stanley og Carnegie køber godt ind i Cantargia....Carnegie har et kursmål på 42, og godt at se de også køber ind. Kan Cantargia være et opkøbsemne?
-
ApS invest...Det kan Cantargia sagtens være.
-
En markedsværdi på 2,6 Milliarder for Cantargia, burde ihvertfald være spiselig for en større aktør. Utroligt spændende selskab.
-
Mesoblast vinder 2020 Fierce Biotech Innovation of the Year Award for remestemcel-L. +7% pre market
- https://finance.yahoo.com/news/mesoblast-wins-2020-fierce-biotech-100000885.html -
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind